v3.26.1
Segment Information -Reconciliation of Total Adjusted EBITDA to Consolidated Income (Loss) Before Income Taxes (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]    
Adjusted EBITDA $ 121,193 $ 127,938
Interest expense, net (25,594) (28,399)
Depreciation and amortization, including patient equipment depreciation (106,469) (94,345)
Equity-based compensation expense (6,500) (5,300)
Loss before income taxes (20,105) (5,229)
Asset dispositions 1,600 2,300
Systems implementation activities   1,600
Other nonoperating income 300  
Transaction costs 900  
Other nonoperating expense   1,200
Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment    
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]    
Interest expense, net (25,594) (28,399)
Depreciation and amortization, including patient equipment depreciation (106,469) (94,345)
Equity-based compensation expense (6,532) (5,296)
Litigation settlement expense (500) 0
Other non-recurring expenses, net (2,203) (5,127)
Loss before income taxes $ (20,105) $ (5,229)